Skip to menu Skip to content Skip to footer
Dr John Mackintosh
Dr

John Mackintosh

Email: 

Overview

Background

MBBS(Hons), FRACP — Specialist Respiratory and Lung Transplant Physician

Dr John Mackintosh graduated from The University of Queensland in 2011 with honours. He trained in respiratory medicine in Queensland, before completing an interstitial lung disease clinical fellowship at the Royal Brompton Hospital in London — one of the world's leading interstitial lung disease (ILD) referral centres.

He returned to Brisbane in 2019 as a Respiratory & Lung Transplant Physician with the Queensland Lung Transplant Service at The Prince Charles Hospital, and as an academic at The University of Queensland, where he was promoted to Associate Professor in recognition of his clinical and research contribution to ILD. He leads The Prince Charles Hospital's ILD service and his research work centres on ILD, with particular expertise in idiopathic pulmonary fibrosis, familial pulmonary fibrosis and the genetic underpinnings of fibrotic lung disease.

Alongside his clinical practice, he co-chairs the Queensland Statewide ILD Multidisciplinary Meeting and is founder and chair of the Australasian ILD Genetics Multidisciplinary Meeting. Internationally, he was a Co-Lead for the International Society of Heart and Lung Transplantation's first consensus statement on short telomere syndrome and lung transplantation, and is first author of the current Thoracic Society of Australia and New Zealand position statement on the treatment of IPF and progressive pulmonary fibrosis.

Availability

Dr John Mackintosh is:
Not available for supervision

Research impacts

Dr Mackintosh's research centres on interstitial lung disease, with a particular focus on the genetics of pulmonary fibrosis, telomere biology disorders and outcomes after lung transplantation.

Works

Search Professor John Mackintosh’s works on UQ eSpace

84 works between 2012 and 2026

61 - 80 of 84 works

2022

Conference Publication

Australia and New Zealand interstitial lung disease registry (ANZ ILD) 2021 update - progress during the pandemic

Moore, I., Wrobel, J., Jackson, D., Mackintosh, J., Glaspole, I., Grainge, C., Wilsher, M. L., Thien, F., Chambers, D., Goh, N., Edwards, A., Gallagher, H., Kwan, B., Veitch, E., Keir, G. and Corte, T. J. (2022). Australia and New Zealand Interstitial Lung Disease Registry (ANZ ILD) 2021 Update - Progress During the Pandemic. International Conference of the American-Thoracic-Society (ATS), San Francisco Ca, May 13-18, 2022. NEW YORK: AMER THORACIC SOC.

Australia and New Zealand interstitial lung disease registry (ANZ ILD) 2021 update - progress during the pandemic

2022

Journal Article

Genomic lung allograft surveillance: is it primer time?

Mackintosh, John A. and Chambers, Daniel C. (2022). Genomic lung allograft surveillance: is it primer time?. The Journal of Heart and Lung Transplantation, 41 (4), 467-469. doi: 10.1016/j.healun.2022.01.016

Genomic lung allograft surveillance: is it primer time?

2022

Conference Publication

Australia and New Zealand interstitial lung disease registry (ANZ ILD) 2021 update - Progress during the pandemic

Moore, , Wrobel, J., Jackson, D., Mackintosh, J., Glaspole, , Grainge, C., Wilsher, M., Thien, F., Chambers, D., Goh, N., Edwards, A., Gallagher, H., Kwan, B., Veitch, E., Keir, G. and Corte, T. (2022). Australia and New Zealand interstitial lung disease registry (ANZ ILD) 2021 update-Progress during the pandemic. HOBOKEN: WILEY.

Australia and New Zealand interstitial lung disease registry (ANZ ILD) 2021 update - Progress during the pandemic

2021

Journal Article

Interstitial pneumonia with autoimmune features: Challenges and controversies

Mackintosh, John A., Wells, Athol U., Cottin, Vincent, Nicholson, Andrew G. and Renzoni, Elisabetta A. (2021). Interstitial pneumonia with autoimmune features: Challenges and controversies. European Respiratory Review, 30 (162) 210177, 210177-162. doi: 10.1183/16000617.0177-2021

Interstitial pneumonia with autoimmune features: Challenges and controversies

2021

Journal Article

TELO-SCOPE study: A randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosis

MacKintosh, John A., Pietsch, Maria, Lutzky, Viviana, Enever, Debra, Bancroft, Sandra, Apte, Simon H., Tan, Maxine, Yerkovich, Stephanie T., Dickinson, Joanne L., Pickett, Hilda A., Selvadurai, Hiran, Grainge, Christopher, Goh, Nicole S., Hopkins, Peter, Glaspole, Ian, Reynolds, Paul N., Wrobel, Jeremy, Jaffe, Adam, Corte, Tamera J. and Chambers, Daniel C. (2021). TELO-SCOPE study: A randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosis. BMJ Open Respiratory Research, 8 (1) e001127, 1-8. doi: 10.1136/bmjresp-2021-001127

TELO-SCOPE study: A randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosis

2021

Journal Article

Disease pathology in fibrotic interstitial lung disease: is it all about usual interstitial pneumonia?

Renzoni, Elisabetta A, Poletti, Venerino and Mackintosh, John A (2021). Disease pathology in fibrotic interstitial lung disease: is it all about usual interstitial pneumonia?. The Lancet, 398 (10309), 1437-1449. doi: 10.1016/S0140-6736(21)01961-9

Disease pathology in fibrotic interstitial lung disease: is it all about usual interstitial pneumonia?

2021

Journal Article

Antifibrotic therapies for idiopathic pulmonary fibrosis

Akbar, Ihya, Mann, Jennifer, Niewodowski, Daniel, Mackintosh, John, Glaspole, Ian N and Barnes, Hayley (2021). Antifibrotic therapies for idiopathic pulmonary fibrosis. Cochrane Database of Systematic Reviews, 2021 (10) CD015076. doi: 10.1002/14651858.CD015076

Antifibrotic therapies for idiopathic pulmonary fibrosis

2021

Journal Article

Protecting the vulnerable: SARS-CoV-2 vaccination in immunosuppressed patients with interstitial lung disease

Mackintosh, John A, Lipman, Marc, Lowe, David M and Renzoni, Elisabetta A (2021). Protecting the vulnerable: SARS-CoV-2 vaccination in immunosuppressed patients with interstitial lung disease. The Lancet Respiratory Medicine, 9 (9), 947-949. doi: 10.1016/S2213-2600(21)00326-X

Protecting the vulnerable: SARS-CoV-2 vaccination in immunosuppressed patients with interstitial lung disease

2021

Journal Article

Benefits of a virtual interstitial lung disease multidisciplinary meeting in the face of COVID-19

Mackintosh, John A., Glenn, Laura, Barnes, Hayley, Dunn, Emily, Bancroft, Sandra, Reddy, Taryn, Teoh, Alan K. Y., Troy, Lauren, Jo, Helen, Geis, Monika, Glaspole, Ian, Grainge, Christopher, Corte, Tamera J., Chambers, Daniel C. and Hopkins, Peter (2021). Benefits of a virtual interstitial lung disease multidisciplinary meeting in the face of COVID-19. Respirology, 26 (6), 612-615. doi: 10.1111/resp.14062

Benefits of a virtual interstitial lung disease multidisciplinary meeting in the face of COVID-19

2021

Journal Article

Airway telomere length in lung transplant recipients

Mackintosh, John A., Yerkovich, Stephanie T., Tan, Maxine E., Samson, Luke, Hopkins, Peter M.A. and Chambers, Daniel C. (2021). Airway Telomere Length in Lung Transplant Recipients. Frontiers in Immunology, 12 658062, 1-7. doi: 10.3389/fimmu.2021.658062

Airway telomere length in lung transplant recipients

2021

Conference Publication

An evaluation of Vitamin D deficiency and supplementation in patients with idiopathic pulmonary fibrosis

Mackintosh, J., Mortimer, N., Kumar, R., Hay, K., Mann, J., Ryder, S., Jo, H., Glaspole, I., Grainge, C., Goh, N., Hopkins, P., Moodley, Y., Reynolds, P., Zappala, C., Allan, H., Keir, G., Hayen, A., Cooper, W., Mahar, A., Ellis, S., Macansh, S., Wells, A., Corte, T. and George, P. (2021). An evaluation of Vitamin D deficiency and supplementation in patients with idiopathic pulmonary fibrosis. TSANZSRS 2021 The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science, Online, 1–2 May 2021. Richmond, VIC Australia: John Wiley & Sons.

An evaluation of Vitamin D deficiency and supplementation in patients with idiopathic pulmonary fibrosis

2020

Journal Article

Successful treatment of telomeropathy‐related interstitial lung disease with immunosuppression and danazol

Chambers, Daniel C., Lutzky, Viviana P., Apte, Simon H., Godbolt, David, Feenstra, John and Mackintosh, John (2020). Successful treatment of telomeropathy‐related interstitial lung disease with immunosuppression and danazol. Respirology Case Reports, 8 (6) e00607, 1-3. doi: 10.1002/rcr2.607

Successful treatment of telomeropathy‐related interstitial lung disease with immunosuppression and danazol

2020

Journal Article

Hiatus hernia and interstitial lung abnormalities

George, Peter M., Hida, Tomoyuki, Putman, Rachel K., Hino, Takuya, Desai, Sujal R., Devaraj, Anand, Kumar, Sacheen, Mackintosh, John A., Gudnason, Vilmundur, Hatabu, Hiroto, Gudmundsson, Gunnar and Hunninghake, Gary M. (2020). Hiatus hernia and interstitial lung abnormalities. European Respiratory Journal, 56 (5) 2001679, 2001679-5. doi: 10.1183/13993003.01679-2020

Hiatus hernia and interstitial lung abnormalities

2019

Journal Article

Familial lung disease presenting in reverse

Mackintosh, John A and Chua, Felix (2019). Familial lung disease presenting in reverse. The Lancet Respiratory Medicine, 7 (12), 1084-12. doi: 10.1016/S2213-2600(19)30403-5

Familial lung disease presenting in reverse

2019

Journal Article

Interstitial lung abnormalities in the Queensland Lung Cancer Screening Study: prevalence and progression over two years of surveillance: ILAs in QLCSS prevalence and progression

Mackintosh, John A., Marshall, Henry M., Slaughter, Richard, Reddy, Taryn, Yang, Ian A., Bowman, Rayleen V. and Fong, Kwun M. (2019). Interstitial lung abnormalities in the Queensland Lung Cancer Screening Study: prevalence and progression over two years of surveillance: ILAs in QLCSS prevalence and progression. Internal Medicine Journal, 49 (7), 843-849. doi: 10.1111/imj.14148

Interstitial lung abnormalities in the Queensland Lung Cancer Screening Study: prevalence and progression over two years of surveillance: ILAs in QLCSS prevalence and progression

2019

Journal Article

Systemic Sclerosis Associated Interstitial Lung Disease: A Comprehensive Overview

Mackintosh, John A., Stainer, Anna, Barnett, Joseph L. and Renzoni, Elisabetta A. (2019). Systemic Sclerosis Associated Interstitial Lung Disease: A Comprehensive Overview. Seminars in Respiratory and Critical Care Medicine, 40 (2), 208-226. doi: 10.1055/s-0039-1683431

Systemic Sclerosis Associated Interstitial Lung Disease: A Comprehensive Overview

2019

Journal Article

In patients with idiopathic pulmonary fibrosis the presence of hiatus hernia is associated with disease progression and mortality

Mackintosh, John A., Desai, Sujal R., Adamali, Huzaifa, Patel, Kinesh, Chua, Felix, Devaraj, Anand, Kouranos, Vasilis, Kokosi, Maria, Margaritopoulos, George, Renzoni, Elisabetta A., Wells, Athol U., Molyneaux, Philip L., Kumar, Sacheen, Maher, Toby M. and George, Peter M. (2019). In patients with idiopathic pulmonary fibrosis the presence of hiatus hernia is associated with disease progression and mortality. European Respiratory Journal, 53 (5) 1802412, 1802412-5. doi: 10.1183/13993003.02412-2018

In patients with idiopathic pulmonary fibrosis the presence of hiatus hernia is associated with disease progression and mortality

2019

Journal Article

Risk of anastomotic dehiscence in patients with pulmonary fibrosis transplanted while receiving anti-fibrotics: experience of the Australian Lung Transplant Collaborative

Mackintosh, John A., Munsif, Maitri, Ranzenbacher, Lucy, Thomson, Claire, Musk, Michael, Snell, Gregory, Glanville, Allan, Chambers, Daniel C. and Hopkins, Peter (2019). Risk of anastomotic dehiscence in patients with pulmonary fibrosis transplanted while receiving anti-fibrotics: experience of the Australian Lung Transplant Collaborative. Journal of Heart and Lung Transplantation, 38 (5), 553-559. doi: 10.1016/j.healun.2019.02.005

Risk of anastomotic dehiscence in patients with pulmonary fibrosis transplanted while receiving anti-fibrotics: experience of the Australian Lung Transplant Collaborative

2019

Journal Article

A targeted approach to the complications of targeted therapy

Mackintosh, John A., Marshall, Henry M. and Fong, Kwun M. (2019). A targeted approach to the complications of targeted therapy. Journal of Thoracic Oncology, 14 (4), 577-579. doi: 10.1016/j.jtho.2018.12.034

A targeted approach to the complications of targeted therapy

2019

Journal Article

Rheumatoid arthritis

Mackintosh, John A., Stainer, Anna, De Sadeleer, Laurens J., Stock, Carmel, Wuyts, Wim A. and Renzoni, Elisabetta A. (2019). Rheumatoid arthritis. ERS Monograph, 2019 (9781849841122), 44-67. doi: 10.1183/2312508X.10014019

Rheumatoid arthritis

Funding

Current funding

  • 2023 - 2028
    Treatable Traits in Interstitial Lung Disease (TTRILD) Study: The New Frontier (MRFF Preventive and Public Health Research Initiative grant administered by The University of Western Australia)
    University of Western Australia
    Open grant

Past funding

  • 2020 - 2025
    The TELO-SCOPE study: Attenuating Telomere Attrition with Danazol. Is there Scope to Dramatically Improve Health Outcomes for Adults and Children with Pulmonary Fibrosis?
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant

Media

Enquiries

For media enquiries about Dr John Mackintosh's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au